Ignite Creation Date:
2024-05-06 @ 1:14 AM
Last Modification Date:
2024-10-26 @ 11:01 AM
Study NCT ID:
NCT01768520
Status:
COMPLETED
Last Update Posted:
2019-07-02
First Post:
2013-01-14
Brief Title:
Evaluation of the Efficacy and Safety of Entelon Tab 150mg in Patients With Osteoarthritis of Knee
Sponsor:
Hanlim Pharm Co Ltd
Organization:
Hanlim Pharm Co Ltd
Study Overview
Official Title:
For 12 Weeks the Multi-center Randomized Double-blinded Clinical Study to Evaluate the Efficacy and Safety of Entelon Tab 150mg Compared With Celebrex Capsule in Patients With Osteoarthritis of Knee Phase III
Status:
COMPLETED
Status Verified Date:
2019-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial is planned to prove Entelon tab arm is not inferior to Celebrex cap arm in terms of the efficacy and safety through the change of K-WOMACs total score sum in patients with osteoarthritis of knee
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None